|
Eosinopenia in COVID-19: What we missed so far? |
journalArticle |
2021 |
Davido, Benjamin; Partouche, Bethsabee; Jaffal, Karim; de Truchis, Pierre; Herr, Marie; Pepin, Marion |
|
Oral ivermectin for a scabies outbreak in a long‐term–care facility: Potential value in preventing COVID‐19 and associated mortality? |
journalArticle |
2021 |
Bernigaud, C.; Guillemot, D.; Ahmed‐Belkacem, A.; Grimaldi‐Bensouda, L.; Lespine, A.; Berry, F.; Softic, L.; Chenost, C.; Do‐Pham, G.; Giraudeau, B.; Fourati, S.; Chosidow, O. |
|
Drivers of ESBL-producing Escherichia coli dynamics in calf fattening farms: A modelling study |
journalArticle |
2021 |
Bastard, J; Haenni, M; Gay, E; Glaser, P; Madec, J.-Y.; Temime, L; Opatowski, L |
|
Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol. |
journalArticle |
2021 |
Azabou, E; Bao, G; Costantino, F; Jacota, M; Lazizi, C; Nkam, L; Rottman, M; Roux, A L; Chevallier, S; Grimaldi, L; Breban, M |
|
[The SMA France national registry: already encouraging results]. |
journalArticle |
2021 |
Lemoine, M; Gomez, M; Grimaldi, L; Urtizberea, J A; Quijano-Roy, S |
|
Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017 |
journalArticle |
2021 |
Cheysson, Felix; Brun-Buisson, Christian; Opatowski, Lulla; Le Fouler, Lenaig; Caserio-Schönemann, Céline; Pontais, Isabelle; Guillemot, Didier; Watier, Laurence |
|
Decreasing trends in potentially inappropriate medications in older people: a nationwide repeated cross-sectional study |
journalArticle |
2021 |
Drusch, Solène; Le Tri, Thien; Ankri, Joël; Zureik, Mahmoud; Herr, Marie |
|
Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries. A systemat |
journalArticle |
2021 |
Lison Ramblière, Didier Guillemot, Elisabeth Delarocque-Astagneaua, Bich-Tram Huynh |
|
Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study). |
journalArticle |
2021 |
Mustafic, H; Fayssoil, A; Josseran, L; Ouadahi, M; Grimaldi-Bensouda, L; Dubourg, O; Annane, D; Mansencal, N |
|
Complement inhibition in severe COVID-19 - Blocking C5a seems to be key: Author''s reply. |
journalArticle |
2021 |
Annane, D; Grimaldi-Bensouda, L; Fremeaux-Bacchic, V |
|
Optimizing COVID-19 surveillance in longterm care facilities: a modelling study |
journalArticle |
2020 |
David R. M. Smith, Audrey Duval, Koen B. Pouwels, Didier Guillemot, Jérôme Fernandes, Bich-Tram Huynh, Laura Temime, Lulla Opatowski & on behalf of the AP-HP/Universities/Inserm COVID-19 research collaboration |
|
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France |
journalArticle |
2020 |
Mahmoud Zureik , Berangere Baricault , Célementine Vabre , Laura SEMENZATO , Jérôme Drouin , François cuenot , Laetitia penso , Philippe Herlemont , Emilie Sbidian , Alain Weill , Mathieu Molimard , Rosemary Dray-Spira , Jeremie Botton |
|
Lockdown impact on age-specific contact patterns and behaviours in France |
journalArticle |
2020 |
Paolo Bosetti , Bich-Tram Huynh , Armiya Youssouf Abdou , Marie Sanchez , Catherine Eisenhauer , Noémie Courtejoie , Jérôme Accardo , Henrik Salje , Didier Guillemot , Mathieu Moslonka-Lefebvre , Pierre-Yves Boëlle , Guillaume Béraud , Simon Cauchemez , Lulla Opatowski |
|
Contributions of modelling for the control of COVID-19 nosocomial transmission |
journalArticle |
|
Lulla Opatowski, Laura Temime |
|
Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS |
journalArticle |
|
Eve Rahbe,Laurence Watier,Didier Guillemot,Philippe Glaser,Lulla Opatowski |